Lifesciences & Pharma
Leading Commercialization Advisory Practice
Genesis is a leading commercialization advisory practice firm in Lifesciences and Pharmaceutical focusing on global markets - EU, USA, LATAM, and beyond. We help facilitate commercialization projects and implement them for our partners.
In & Out Licensing
Buy Side Advisory
Mergers & Acquisitions
Commercial & Market Due Diligence
Post Close Services
Portfolio Management.
Commercialization Services
At Genesis, we help pharma, biotech, nutraceutical, and healthtech companies turn innovation into impact. From early product planning to market launch, we deliver strategies that ensure clarity, speed, and precision.
Market sizing, segmentation, positioning, and clinical input aligned with commercial goals.
Data-driven brand, lifecycle, and competitive positioning strategies.
Market prioritization, channel strategy, pricing, reimbursement, and launch planning.
Define product attributes, guide strategy, and benchmark against market needs.
Competitor profiling, pipeline tracking, and strategic market intelligence.
Pharmaceutical Product Modalities
- Finished Formulations
- APIs
- Antibodies, ADCs
- Biomarkers
- Cell Therapy
- Diagnostics
- Discovery Platforms
- DNA/RNA Drugs
- Medical Devices
- Medtech Software
- Microbiome Drugs
- Oncolytic Virus
- Peptides/Protein Drugs
- Small Molecules
- Vaccines
Regulatory Strategy, Compliance & Legal Advisory
We help you build robust, forward-looking regulatory strategies that align with product development, commercialization goals, and global market requirements. Our services include:
- Regulatory Intelligence & Impact Analysis
- Global Regulatory Submissions (FDA, EMA, CDSCO, ANVISA, TGA, etc.)
- Clinical & Non-Clinical Regulatory Support
- Interim Regulatory Affairs Team Support
- Product Registration & Dossier Preparation
- Regulatory Market Entry
- Regulatory Due Diligence for licensing deals, acquisitions, and partnerships
Intelligence & Insights
At Genesis, we equip organizations with actionable market and regulatory intelligence to drive confident, high-impact decisions. Our expertise spans pharma, consumer products, APIs, nutraceuticals, medtech, diagnostics, and industrial sectors like chemicals and minerals.
Assess product–market fit, demand drivers, competitive gaps, regulatory pathways, and readiness.
Map competitors, track pipelines, analyze innovation trends, and benchmark portfolios.
Continuous tracking of regulatory changes, trial requirements, marketing authorizations, and compliance obligations.
Deliver actionable insights on new regulations, evaluate performance against industry norms, and identify areas for process optimization.
Support decision-making, risk mitigation, and global filing strategies to accelerate approvals and reduce compliance risks.
Disease Areas
- Autoimmune/Immunology
- Congenital Disorders
- Endocrine and Metabolic
- Hematology
- Injuries and Trauma
- Oncology
- Respiratory
- Cardiovascular
- Dermatology/Aesthetics
- Fibrosis
- Infectious Disease
- Musculoskeletal
- Ophthalmology
- Urology (non-onc)
- Central Nervous System
- Digestive/GI
- Genitourinary Diseases
- Inflammation/Pain
- Non-Medical
- Orphan Diseases
- Women’s Health
We Consult in Nutraceuticals Across Types
- Functional Foods
- Dietary Supplements
- Clinical Nutrition
- Probiotics/Prebiotics
- Branded Ingredients/APIs
Orphan Drugs
We are a specialized consulting firm supporting pharmaceutical companies across Europe, LATAM, and global markets with integrated launch solutions and phase-appropriate strategies to transition from clinical to commercial success.
We are specialised to handle “delicate” products that we can pack with care (eg. High cost and delicate products like biologics with an extremely short amount of time out of fridge).
We have the expertise and capacity to manage complex supply chains and commercial serialization capabilities to support your commercial packaging needs.
GENESIS ENDEAVOURS TO SOURCE RARE DISEASE DRUGS FOR CUSTOMERS GLOBALLY.